FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
PO:14:204 | Risk stratification in systemic lupus erythematosus patients: improving the performances of a prediction model Lucia Lanzo1, Silvia Laura Bosello1, Livia Lilli2, Laura Antenucci2, Carlotta Masciocchi2, Marco Gorini3, Gabriella Castellino3, Luca Petricca1, Maria Rita Gigante1, Vivianaantonella Pacucci1, Pier Giacomo Cerasuolo1, Silvia Piunno1, Francesco Cristiano1, Cesare Gavotti1, Pier Luigi Rizzuti1, Rebecca Ventura1, Jacopo Lenkowicz2, Alfredo Cesario2, Stefano Patarnello2, Maria Antonietta D'Agostino1. | 1UOC di Reumatologia e Immunologia clinica - Fondazione Policlinico Universitario A. Gemelli IRCSS, UCSC, Roma, Italy; 2Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Roma, Italy; 3AstraZeneca MIND, Milano, Italy.
245 -
PO:35:234 | Sustained Vasculitis Quiescence and CS Reduction with Mepolizumab 100 mg Francesca Mascia1, Angelo Fassio2, Marco Zurlo1, Davide Chesini3, Francesco Pollastri2, Giovanni Adami2, Davide Gatti4, Maurizio Rossini4, Matteo Maule5, Gianentrico Senna1, Marco Caminati1 | 1University of Verona - Allergology and Clinical Immunology Verona, Italy; 2Policlinico G. B. Rossi - Rheumatology Verona, Italy; 3University of Verona - Faculty of Medicine and Surgery Verona, Italy; 4University of Verona - Rheumatology Verona, Italy; 5Policlinico G. B. Rossi - Allergology and Clinical Immunology Verona, Italy
68 -
PO:35:228 | Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors for cancer treatment: a systematic review and meta-analysis highlighting differences from the idiopathic forms Elvis Hysa1, Andrea Casabella2, Emanuele Gotelli1, Rosanna Campitiello1, Carlo Genova3, Enrica Teresa Tanda4, Carmen Pizzorni1, Alberto Sulli1, Vanessa Smith5, Marco Amedeo Cimmino6, Sabrina Paolino1, Maurizio Cutolo1. | 1Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, Genova, Italy; 2IRCCS Ospedale Policlinico San Martino, Genova, Italy; 3Academic Oncology Unit; IRCCS Ospedale Policlinico San Martino, Genova, Italy; 4UOC Medical Oncology Clinic 2, Department of Internal Medicine, University of Genova, Genova, Italy; 5Department of Internal Medicine, Ghent University, Department of Rheumatology, Ghent University Hospital, Ghent, Belgium; 6Rheumatology Outpatient Clinic, Villa Ravenna Chiavari Italy.
247 -
PO:12:177 | Systemic inflammation and QTc interval prolongation in new-onset polymyalgia rheumatica: the effect of corticosteroid therapy Anna Colangelo1, Riccardo Accioli2, Viola Salvini2, Francesco Tromby1, Giulia Cruciani1, Martina Nicchi1, Biancamaria Pianese1, Francesca Lalli1, Anna Cantore2, Caterina Antonini1, Decoroso Verrengia2, Andrea Castellucci1, Giacomo Cafaro1, Carlo Perricone1, Roberto Gerli1, Pietro Enea Lazzerini2, Elena Bartoloni1 | 1SC Reumatologia. Università di Perugia, Italy; 2Dipartimento di Scienze Mediche, Università di Siena, Italy
133 -
PO:20:002 | Respiratory function tests predict bone mineral density in autoimmune rheumatic disease patients Andrea Zoli1, Panagiotis Garantziotis2, Sebastian Böltz2, Janina Auth2, Sara Bayat2, Jule Taubmann2, Anna-Maria Liphardt2, Maria Antonietta D'Agostino1, Christina Bergmann2, Georg Schett2. | 1Division of Rheumatology, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy; 2Department of Medicine 3, Rheumatology and Immunology, Friedrich Alexander Universität FAU, Erlangen, Germany.
233 -
CO:10:2 | Common variable immunodeficiency patients complicated by autoimmune and inflammatory rheumatic manifestations reveal high frequency of genetic variants potentially linked to inborn errors of immunity Paolo Semeraro1, Micol Frassi1, Silvia Clara Giliani2, Franco Franceschini1, Paolo Airò1. | 1Rheumatology and Clinical Immunology Unit, ERN ReCONNET, ASST Spedali Civili of Brescia and University of Brescia; 2Medical Genetic Laboratory, ASST Spedali Civili of Brescia and University of Brescia, Italy
1032 -
-
-
CO:12:4 | Predicting 12-month clinical relapse in Takayasu arteritis using [18F]FDG PET and convolutional neural networks Alessandro Tomelleri1, Carolina Bezzi2, Sara Resta2, Corrado Campochiaro1, Federico Fallanca2, Elena Baldissera1, Samuele Ghezzo2, Nicola Farina1, Arturo Chiti2, Paola Mapelli2, Marco Matucci-Cerinic1, Maria Picchio2, Lorenzo Dagna1. | 1IRCCS Ospedale San Raffaele, Unità di Immunologia Reumatologia Allergologia e Malattie Rare, Milano; 2IRCCS Ospedale San Raffaele, Unità di Medicina Nucleare, Milano, Italy
271 -
PO:23:052 | Muscular and myocardial involvement in antisynthetase syndrome: a retrospective real-life study Giulia Buonsante1|2|3, Giacomo De Luca1|2|3, Veronica Batani1|2, Daniele Scaramuzzi1|2|3, Lorenzo Dagna1|2|3, Marco Matucci-Cerinic1|2|3, Corrado Campochiaro1|2|3. | 1Unit of Immunology, Rheumatology, Allergy and Rare Diseases UNIRAR, IRCCS San Raffaele Hospital, Milano, Italy; 2Inflammation, Fibrosis and aging Initiative INFLAGE, IRCCS San Raffaele Hospital, Milano, Italy; 3Vita-Salute San Raffaele University, Milan, Italy, Milano, Italy.
251 -
Outcome predictors in rheumatoid arthritis
1116Downloads: 1104 -
PO:16:231 | Differential clinical features of systemic lupus erythematosus patients on biological therapies: insights from a monocentric cohort Pietro Francesco Pilo, Elisa Bellis, Claudia Garulli, Claudio Cruciani, Marta Saracco, Claudia Lomater, Elena Marucco, Gloria Crepaldi, Valeria Data, Annamaria Iagnocco, Mariele Gatto. | Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, AO Mauriziano, Torino, Italy.
234 -
PO:20:014 | Post-partum osteoporosis: severe clinical presentation in absence of known risk factors Domenico Birra1, Ludovica Frances Grasso2, Vittoria Gammaldi1, Antonietta De Sena1, Carmine Pio Petrosino2, Rosalia Boccia2, Gabriella Oliva1, Vincenzo Nuzzo1 | 1Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma; 2Istituto Superiore di Sanità, Roma
247 -
The history of antiphospholipid syndrome
3545Downloads: 3385 -
CO:05:3 | Radiomics and machine learning for differentiating rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis with usual interstitial pneumonia pattern Vincenzo Venerito1, Chiara Nani2, Andreina Manfredi3, Marco Fornaro1, Giuseppe Lopalco1, Florenzo Iannone1, Cecilia Burattini2, Marco Sebastiani4. | 1Rheumatology Unit, University of Bari; 2Respiratory Unit, Guglielmo da Saliceto Civil Hospital, Piacenza; 3Rheumatology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia; 4Rheumatology Unit, AUSL Piacenza, University of Parma, Italy
376 -
PO:34:209 | Increased liver stiffness and fibrosis in systemic sclerosis: a single-center transient elastography cohort study. Nicola Ortalli1|2, Simone Aldo Lari1|2, Alessandra Vacca3, Erika Meleddu1|2, Alberto Civolani4, Emanuela Vargiu4, Alberto Floris1|2, Massimo Claudio Fantini4, Alberto Cauli1|2. | 1Rheumatology Unit, Azienda Ospedaliero Universitaria di Cagliari, Cagliari, Italy; 2Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy; 3Rheumatology Unit, Presidio Ospedaliero CTO di Iglesias Iglesias Italy; 4Gastroenterology Unit, Azienda Ospedaliero Universitaria di Cagliari, Cagliari, Italy.
232 -
CO:09:5 | LDL-cholesterol goal attainment with ezetimibe and bempedoic acid in patients with rheumatoid arthritis: a simulation study in the Italian CORDIS cohort Alessandro Giollo1, Kiren Khalid1, Luca Bonanni2, Nicola Ferri3, Gianluca Erre4, Matteo Piga5, Elena Bartoloni6, Andreina Manfredi7, Enno Giulio Favalli8, Maria Sole Chimenti9, Serena Guiducci10, Eleonora Celletti11, Addolorata Corrado12, Simone Parisi20, Ivan Giovannini13, Elisa Gremese14, Garifallia Sakellariou15, Ombretta Viapiana16, Marco Fornaro19, Fabiola Atzeni17, Francesca Romana Spinelli18, Fabio Cacciapaglia19 | 1Università di Padova Padova, Italy; 2UO Medicina Interna ULSS3 Mestre, Italy; 3Università di Padova, Department of Pharmaceutical and Pharmacological Sciences, University of Padova Padova, Italy; 4Università di Sassari Sassari, Italy; 5Università di Cagliari Cagliari, Italy; 6Univeristà degli studi di Perugia Perugia, Italy; 7Università di Modena e Reggio Emilia, UO di Reumatologia Ospedale Policlinico di Modena Reggio Emilia, Italy; 8IRCCS Humanitas Research Hospital, Rozzano Milano, Italy; 9Università Tor Vergata Roma, Italy; 10Università di Firenze Firenze, Italy; 11Ospedale SS. Annunziata Chieti, Italy; 12Università degli studi di Foggia Foggia, Italy; 13Università di Udine, Clinica di Reumatologia Udine, Italy; 14Università degli studi di Milano Milano, Italy; 15Università degli Studi di Pavia Pavia, Italy; 16Università di Verona Verona, Italy; 17Università degli Studi di Messina Messina, Italy; 18Università La Sapienza Roma, Italy; 19Università di Bari, Reumatologia Universitaria Policlinico di Bari Bari, Italy; 20S.C. di Reumatologia A.O.U. Città della Salute e della Scienza di Torino - Ospedale Molinette Torino, Italy
67 -
CO:10:6 | Impact of pregnancy on organ damage in systemic lupus erythematosus: a prospective multicenter study Giancarlo Cascarano1, Greta Hulej2, Dina Zucchi1, Antonia Calligaro2, Elena Elefante1, Luca Iaccarino2, Sabrina Gori1, Margherita Zen2, Chiara Tani1, Andrea Doria2, Marta Mosca1. | 1Università degli Studi di Pisa; 2Università degli Studi di Padova, Italy
241 -
PO:07:096 | Safety of filgotinib in the treatment of rheumatoid arthritis: results from the multicentre SOFIA study Anna Giorgia Osele1, Matteo Filippini2, Eugenio Capparelli3, Eleonora Bruschi4, Bernd Raffeiner5, Silvano Bettio6, Mariangela Salvato1, Federico Arru7, Massimiliano Limonta4, Paola Faggioli3, Elda Piovani2, Eleonora Zaccara3, Alessandro Giollo1, Margherita Zen1 | 1UOC Reumatologia, Azienda Ospedale-Università di Padova; 2UO Reumatologia e Immunologia Clinica, ASST Spedali Civili, Brescia; 3UOC Ruematologia, ASST Ovest Milanese, Legnano MI; 4SSD Reumatologia, ASST Papa Giovanni XXIII, Bergamo; 5Dipartimento di Reumatologia, Ospedale di Formazione Paracelsus ASDAA-SABES, Bolzano; 6Medicina Generale Unità 1^, Centro Regionale per le Malattie Rare Immunologiche e Reumatologiche, Ospedale Universitario Treviso; 7UO Medicina, ASL 3 Nuoro, Italy
235 -
PO:17:259 | Anifrolumab: a new management of SLE Giorgia Montozzi1, Chiara Cocco1, Ramona Santangeli1, Lucia Gamba1, Paola Fioretti1, Letizia Curina1, Chiara Guidoni1, Edoardo Cipolletta3, Gianluca Moroncini2 | 1Scuola di Specializzazione in Medicina Interna, Università Politecnica delle Marche Ancona, Italy; 2Department of Clinical and Molecular Sciences, Università Politecnica delle Marche Ancona, Italy; 3Rheumatology Unit, Department of Clinical and Molecular Sciences , Università Politecnica delle Marche Ancona, Italy
184 -
PO:22:029 | Impact of mepolizumab on idiopathic hypereosinophilic syndromes: analysis of a monocentric retrospective cohort Jacopo Mora1, Francesca Regola1, Paola Toniati2, Ilaria Cavazzana1, Franco Franceschini1. | 1ASST Spedali Civili e Università degli Studi di Brescia, Brescia, Italy; 2ASST Spedali Civili di Brescia, Brescia, Italy.
202 -
S13:5 | Association between vasoactive-vasodilating therapy and reduced detection of pulmonary arterial hypertension in systemic sclerosis: evidence from a European Scleroderma Trials and Research study Nicola Farina1, Silvia Bellando-Randone1, Sebastien Sanges2, Hilde Jenssen Bjørkekjær3, Lorenzo Tofani4, Marie-Elise Truchetet5, Vanessa Smith6, Andra Balanescu7, Christina Bergmann8, Yannick Allanore9, Philipp Klemm10, Simona Truglia11, Luca Idolazzi12, Christopher Denton13, Roberta Foti14, Anna Wojteczek15, Emmanuel Chatelus16, Madelon Vonk17, Serena Guiducci1, David Launay2, Eric Hachulla2, Jeska De Vries-Bouwstra18, Anna-Maria Hoffmann-Vold19, Oliver Distler20, Marco Matucci-Cerinic1, Cosimo Bruni1. | 1Department of Experimental and Clinical Medicine, Scleroderma Unit, Division of Rheumatology, University of Florence, Az, Firenze, Italy; 2Univ. Lille, Inserm, CHU Lille, Department of Internal Medicine and Clinical Immunology, Reference Center for Rare Autoi, Lille, France; 3Department of Rheumatology, Hospital of Southern Norway, Kristiansand, Norway; 4Department of Statistics, Informatics and Applications, University of Florence, Firenze, Italy; 5Rheumatology department, CHU de Bordeaux, Bordeaux, France; 6University of Ghent, Department of Rheumatology, Gent, Belgium; 7Department of Rheumatology, St. Maria Hospital, Carol Davila, University of Medicine and Pharmacy Bucharest Romania; 8Department Internal Medicine 3, University Hospital Erlangen, Erlangen, Germany; 9Rheumatology Department, Université Paris Cité, Cochin Hospital, Paris, France; 10Department of Rheumatology and Clinical Immunology Center, JLU Giessen, Campus Kerckhoff Bad Nauheim Germany; 11Reumatologia, Azienda Ospedaliero-Universitaria Policlinico Umberto I, Roma, Italy; 12Section of Rheumatology, Department of Medicine, University of Verona, Verona, Italy; 13Centre for Rheumatology, Royal Free London and University College London Medical School, London, United Kingdom; 14Division of Rheumatology, A.O.U. Policlinico-San Marco, Catania, Italy; 15Department of Rheumatology, Clinical Immunology, Geriatrics and Internal Medicine, Medical University of Gdansk, Univers Gdansk Poland; 16Department of Rheumatology, University Hospital Strasbourg Strasbourg France; 17Department of rheumatology, Radboud University Nijmegen Medical Center Nijmegen The Netherlands; 18Department of Rheumatology, Leiden University Medical Center Leiden The Netherlands; 19Department of Rheumatology, Oslo University Hospital, Oslo, Norway; 20Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
206
